RecruitingNCT04295252
Altshock-2 REGISTRY
Cardiogenic Shock: a Prospective National Registry to Get Insights in Patients' Profile, Management and Outcome
Sponsor
Niguarda Hospital
Enrollment
3,000 participants
Start Date
Jul 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The study will provide data on profile, management, outcome, and evolution over time of cardiogenic shock patients admitted to the Intensive Coronary Care Units
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- All consecutive CS patients hospitalized in the above reported centres between January 2020 and December 2030.
- Cardiogenic shock is defined as:
- Systolic blood pressure (SBP) <90 mmHg or mean arterial pressure (MAP) <60 mmHg, after an appropriate fluid challenge if there is no sign of overt fluid overload, OR need of vasoactive agents to maintain SBP > 90 mmHg or MAP > 60 mmHg, OR need of MCS;
- At least one of the following criteria/signs of overt hypoperfusion: mixed venous oxygen saturation <60%; arterial lactates > 2 mmol/L; oliguria < 0.5 ml/Kg/h for at least 6 hours.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04295252
Related Trials
Abiomed Impella RT-DAQ - Observational Study
NCT063080554 locations
Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)
NCT075972911 location
BEAT-SHOCK Registry
NCT076436101 location
OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science
NCT076191441 location
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
NCT056990051 location